Skip to main content
Journal ArticleOPEN ACCESS

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration

  • Roller A
  • Amaro M
Arquivos Brasileiros de Oftalmologia (2009) 72(5) 677-681
DOI: 10.1590/s0004-27492009000500016
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

To investigate the efficacy of vascular endothelial growth factor-specific (VEGF) monoclonal antibodies in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) that does not extend beneath the foveal center (nonsubfoveal CNV).

Cite

CITATION STYLE

APA

Roller, A. B., & Amaro, M. H. (2009). Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration. Arquivos Brasileiros de Oftalmologia, 72(5), 677–681. https://doi.org/10.1590/s0004-27492009000500016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free